Dexycu (dexamethasone intraocular injection) / EyePoint Pharma, Ocumension Therap  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Dexycu (dexamethasone intraocular injection) / EyePoint Pharma, Ocumension Therap
DEXYCURetro, NCT04290676: DEXYCU (Dexamethasone Intraocular Suspension) 9% Retrospective Study 001

Completed
N/A
527
US
DEXYCU (dexamethasone intraocular suspension) 9%., dexamethasone intraocular suspension
EyePoint Pharmaceuticals, Inc.
Cataract
05/20
05/20

Download Options